Form 4: HeartBeam Director Mark Strome Acquires and Disposes of Shares

Director Mark Strome reports acquisition of restricted stock units and disposal of common stock in HeartBeam, Inc.

Summary

• On June 12, 2024, Mark Strome, a director of HeartBeam, Inc., acquired 33,185 restricted stock units (RSUs), each representing a contingent right to receive one share of Common Stock.
• On the same day, Strome disposed of 57,146 shares of Common Stock.
• Following these transactions, Strome directly owns 57,146 shares of Common Stock.
• Strome also indirectly owns 3,150,000 shares through Strome Mezzanine Fund II, LP, Mark E. Strome Living Trust, and Strome Dynasty, LLC.
• The RSUs vest on the earlier of June 12, 2025, or the date of the Issuer's 2025 annual meeting of stockholders, contingent on Strome remaining an Outside Director.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is common in the biotech/medical device industry. These transactions can be influenced by various factors, including personal financial planning and company performance.

Stakeholder Impact

• Shareholders may be interested in insider transactions as an indicator of management's confidence in the company.
• The transactions themselves are unlikely to have a significant impact on other stakeholders.

Key Dates